Publication
Preclinical target validation using patient-derived cells
Aled M. Edwards, Cheryl H. Arrowsmith, Chas Bountra, Mark E. Bunnage, Marc Feldmann, Julian C. Knight, Dhavalkumar D. Patel, Panagiotis Prinos, Michael D. Taylor, Michael Sundström, Phil Barker, Dalia Barsyte, Mario H. Bengtson, Cindy Bell, Paul Bowness, Kym M. Boycott, Carolyn Buser-Doepner, Christopher L. Carpenter, Andrew J. Carr, Kirk Clark, Anuk M. Das, Dashyant Dhanak, Peter Dirks, James Ellis, Valeria R. Fantin, Christopher Flores, Edward A. Fon, Donald E. Frail, Opher Gileadi, Ronan C. O'Hagan, Trevor Howe, John T. R. Isaac, Nada Jabado, Per-Johan Jakobsson, Lars Klareskog, Stefan Knapp, Wen Hwa Lee, Evelyne Lima-Fernandes, Ingrid E. Lundberg, John Marshall, Katlin B. Massirer, Alex E. MacKenzie, Tetsuyuki Maruyama, Anke Mueller-Fahrnow, Senthil Muthuswamy, Jagdeep Nanchahal, Catherine O'Brien, Udo Oppermann, Nils Ostermann, Kevin Petrecca, Bruce G. Pollock, Viviane Poupon, Rab K. Prinjha, Saul H. Rosenberg, Guy Rouleau, Malcolm Skingle, Arthur S. Slutsky, Garth A. M. Smith, Dominique Verhelle, Hans Widmer, L. Trevor Young
Nature Reviews Drug Discovery, February 2015, Springer Science + Business Media
DOI: 10.1038/nrd4565